Cargando…

Inhibition of CSRP2 Promotes Leukemia Cell Proliferation and Correlates with Relapse in Adults with Acute Myeloid Leukemia

BACKGROUND: Relapse is a major obstacle in the treatment of acute myeloid leukemia (AML). Reﬁnement of risk stratiﬁcation may aid the identiﬁcation of patients who are likely to relapse. Abnormal cysteine and glycine-rich protein 2 (CSRP2) has been implicated in various cancers, but its function rem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Shujuan, Zhang, Yu, Liu, Yajun, Zheng, Ruyue, Wu, Zhenzhen, Fan, Yi, Li, Mengya, Li, Menglin, Li, Tao, Li, Yafei, Jiang, Zhongxing, Wang, Chong, Liu, Yanfang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733086/ https://www.ncbi.nlm.nih.gov/pubmed/33324073 http://dx.doi.org/10.2147/OTT.S281802

Ejemplares similares

Downregulation of SMIM3 inhibits growth of leukemia via PI3K-AKT signaling pathway and correlates with prognosis of adult acute myeloid leukemia with normal karyotype
por: Liu, Yu, et al.
Publicado: (2022)

Downregulation of GNA15 Inhibits Cell Proliferation via P38 MAPK Pathway and Correlates with Prognosis of Adult Acute Myeloid Leukemia With Normal Karyotype
por: Li, Mengya, et al.
Publicado: (2021)

Mutational spectrum and prognosis in NRAS-mutated acute myeloid leukemia
por: Wang, Shujuan, et al.
Publicado: (2020)

An easy-to-use nomogram predicting overall survival of adult acute lymphoblastic leukemia
por: Liu, Yu, et al.
Publicado: (2022)

Risk factors affect accurate prognosis in ASXL1-mutated acute myeloid leukemia
por: Fan, Yi, et al.
Publicado: (2021)

Advances of target therapy on NOTCH1 signaling pathway in T-cell acute lymphoblastic leukemia
por: Zheng, Ruyue, et al.
Publicado: (2020)

A Novel Immune-Related Competing Endogenous RNA Network Predicts Prognosis of Acute Myeloid Leukemia
por: Wang, Shujuan, et al.
Publicado: (2020)

Cysteine and glycine-rich protein 2 (CSRP2) transcript levels correlate with leukemia relapse and leukemia-free survival in adults with B-cell acute lymphoblastic leukemia and normal cytogenetics
por: Wang, Shu-Juan, et al.
Publicado: (2017)

Silencing long non-coding RNA XIST suppresses drug resistance in acute myeloid leukemia through down-regulation of MYC by elevating microRNA-29a expression
por: Wang, Chong, et al.
Publicado: (2020)

LINC00665 Promotes the Progression of Multiple Myeloma by Adsorbing miR-214-3p and Positively Regulating the Expression of PSMD10 and ASF1B
por: Wang, Chong, et al.
Publicado: (2020)

Gene mutational analysis by NGS and its clinical significance in patients with myelodysplastic syndrome and acute myeloid leukemia
por: Yu, Jifeng, et al.
Publicado: (2020)

CSRP2 transcript levels after consolidation therapy increase prognostic prediction ability in B-cell acute lymphoblastic leukemia
por: Cao, Lei-Ming, et al.
Publicado: (2023)

Tumor-suppressive MEG3 induces microRNA-493-5p expression to reduce arabinocytosine chemoresistance of acute myeloid leukemia cells by downregulating the METTL3/MYC axis
por: Wang, Airong, et al.
Publicado: (2022)

Isolated leukemia cutis as extramedullary relapse of acute myeloid leukemia
por: Dadrass, Farinoosh, et al.
Publicado: (2022)

Treatment of Relapsed Acute Myeloid Leukemia
por: Thol, Felicitas, et al.
Publicado: (2020)

Advances in targeted therapy for acute myeloid leukemia
por: Yu, Jifeng, et al.
Publicado: (2020)

Clinical implications of recurrent gene mutations in acute myeloid leukemia
por: Yu, Jifeng, et al.
Publicado: (2020)

Treatment for Relapsed/Refractory Acute Myeloid Leukemia
por: Thol, Felicitas, et al.
Publicado: (2021)

Pembrolizumab and decitabine for refractory or relapsed acute myeloid leukemia
por: Goswami, Meghali, et al.
Publicado: (2022)

Plasmacytoid Dendritic Cells Proliferation Coexisted with Acute Myeloid Leukemia
por: Wang, Min, et al.
Publicado: (2018)

The CSRP2BP histone acetyltransferase drives smooth muscle gene expression
por: Ma, Yanlin, et al.
Publicado: (2017)

Late relapse in acute myeloid leukemia (AML): clonal evolution or therapy-related leukemia?
por: Yilmaz, Musa, et al.
Publicado: (2019)

Isolated Intracranial Myeloid Sarcoma Occurring as Relapse in Acute Myeloid Leukemia
por: Narayanan, Geetha, et al.
Publicado: (2017)

Relapsing acute myeloid leukemia presenting as hypopyon uveitis
por: Hegde, Sapna P, et al.
Publicado: (2011)

Acute promyelocytic leukemia relapsing into acute myeloid leukemia-M2 with normal cytogenetics
por: Sahoo, Ranjit Kumar, et al.
Publicado: (2013)

Acute Myeloid Leukemia Acquiring Promyelocytic Leukemia-Retinoic Acid Receptor Alpha at Relapse
por: Gupta, Varsha, et al.
Publicado: (2019)

Correlation Analysis and Prognostic Impacts of Biological Characteristics in Elderly Patients with Acute Myeloid Leukemia
por: Li, Fengli, et al.
Publicado: (2022)

Notch2 inhibits proliferation of chronic myeloid leukemia cells
por: YANG, ZESONG, et al.
Publicado: (2013)

Significance of bone marrow fibrosis in acute myeloid leukemia for survival in the real-world
por: Zhang, Xia, et al.
Publicado: (2022)

Colonic Myeloid Sarcoma as a Rare Presentation of Relapsed Acute Myeloid Leukemia
por: Phatharacharukul, Parkpoom, et al.
Publicado: (2020)

PB1848: IN VITRO CHEMOSENSITIVITY ASSAY PREDICTS TREATMENT RESPONSE IN RELAPSED AND REFRACTORY ACUTE MYELOID LEUKEMIA
por: Cao, Yigeng, et al.
Publicado: (2023)

Improved outcome of children with relapsed/refractory acute myeloid leukemia by addition of cladribine to re‐induction chemotherapy
por: Ruan, Min, et al.
Publicado: (2021)

Isolated Central Nervous System Relapse in Chronic Myeloid Leukemia
por: Gomez, Juliana, et al.
Publicado: (2015)

Current Approaches in the Treatment of Relapsed and Refractory Acute Myeloid Leukemia
por: Ramos, Nestor R., et al.
Publicado: (2015)

Clonal evolution of acute myeloid leukemia from diagnosis to relapse
por: Vosberg, Sebastian, et al.
Publicado: (2019)

Genomic and evolutionary portraits of disease relapse in acute myeloid leukemia
por: Rapaport, Franck, et al.
Publicado: (2021)

Brachytherapy for uterine cervix-limited acute myeloid leukemia relapse
por: Beziat, Guillaume, et al.
Publicado: (2022)

Venetoclax with Decitabine or Azacitidine in Relapsed or Refractory Acute Myeloid Leukemia
por: Bouligny, Ian M., et al.
Publicado: (2023)

Convergent Epigenetic Evolution Drives Relapse in Acute Myeloid Leukemia
por: Nuno, Kevin A., et al.
Publicado: (2023)

CD36 Drives Metastasis and Relapse in Acute Myeloid Leukemia
por: Farge, Thomas, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_p4l85nhbg94scfdu1q75kuk9hj